An availability of new treatments available through the Pharmaceutical Benefits Scheme (PBS) has seen a significant reduction in Hepatitis C rates in the Alexander Maconochie Centre (AMC).
In 2010, approximately 30 per cent of detainees at the AMC, who had agreed to be screened, were found to be Hepatitis C positive. In July 2017, with additional Hepatitis C treatments made available through the PBS, those figures have reduced to 3 per cent.
“Between March 2016 and March 2017, 58 detainees commenced the new Hepatitis C treatment, with 55 of these detainees experiencing effective treatment outcomes in managing their condition,” said Minister for Corrections Shane Rattenbury.
“The new treatments available through the PBS are providing better health outcomes and greater flexibility for people with Hepatitis C in treating their condition.
“This is a great outcome and I would like to take this opportunity to acknowledge the team from Justice Health Services and ACT Corrective Services for their dedication to improving health outcomes of ACT detainees.”
The AMC Hepatitis C treatment program is a nurse-lead program. Patients are identified though screening at admission to AMC, health consultations, and self or peer referral. As treatment commences, patients consult with nurses for ongoing support and pathology.
Today marks World Hepatitis Day (28 July 2017). This year’s World Hepatitis Day theme is Show Your Face, which aims to reduce stigma associated with blood borne viruses.
Interviews with clinicians are available on request.
- Statement ends -
Section: Shane Rattenbury, MLA | Media Releases
(02) 6205 3897
0481 035 764